期刊文献+

杀虫抗生素米尔贝乳油制剂的加工配方探讨 被引量:1

Study on processing formula of insecticidal antibiotic Milbemycin EC
下载PDF
导出
摘要 由米尔贝(Milbemycins)原药的理化性质可知其可以加工成乳油制剂,研究通过筛选相关辅助剂(溶剂、乳化剂、光稳定剂)配制出5%米尔贝乳油,并完成产品质量分析,最后进行实验室小样的药效试验。结果表明,5%米尔贝乳油配方如下:有效成分含量≥5%,6.8%NP10,1.2%EL90,1%抗氧化剂1010,2%乙酸乙酯,溶剂油200#补足至100%。小样的各项理化性能指标符合国家标准规定,且在稀释30000~50000倍时红蜘蛛的校正死亡率均能达到95%以上。 According to physico-chemical properties of Milbemycin raw material,which can be made into emulsifiable concentrate(EC).This study tried to screen related auxiliary agents(solvents,emulsifier,light stabilizer) in order to get the fomula of 5% Milbemycin EC,finnished the product quality analysis and laboratory test to red mite.The results showed that the fomula was as follows:a.i.≥5%,6.8% NP10,1.2% EL90,1% antioxidant 1010,2% ethylacetate,the others was solvent oil 200#,and added 100%.The physical and chemical properties index of small sample conforming to national standards,and the control effect was well to red mite in the diluting 30 000-50 000 times,the adjusted mortality could reach more than 95%.
出处 《东北农业大学学报》 CAS CSCD 北大核心 2010年第5期28-32,共5页 Journal of Northeast Agricultural University
基金 东北农业大学创新团队科研基金资助
关键词 杀虫抗生素 米尔贝 乳油 配方 防效 insecticidalantibiotics Milbemycin EC formula controleffect
  • 相关文献

参考文献20

  • 1Mishima H,Ide J,Muramatsu S,et al.Milbemycins,a new family of maerolide antibiotics structure determination of Milbemycins[J].Journal of Antibiotics,1983(8):980-990.
  • 2Okazaki T,Ono M.Milbemycins,a new family of maerolide antibiotics:producing organism and its mutants[J].J Antibiotics,1983,36:438-441.
  • 3Zhang X L,Chen Z,Li M,et al.Construction of ivermectin producer by domain swaps of avenneetin polyketide synthase in Streptomyces avermitilis[J].Microbiol Biotechnol,2006,72:986-994.
  • 4Chamberland,Lee S,Lomovskaya M,et al.Fungal efflux pump inhibitors:US,6495591 B1[S].2002-12-17.
  • 5袁德凯,赵卫光,李正名.Milbemycins的结构修饰[J].农药学学报,2003,5(1):1-11. 被引量:2
  • 6Aoki,Atsushi,Fukuda,et al.Antibiotic substances 8-41,their production and their use as insecticides and acaricides:US,3998699[P].1975-05-01.
  • 7Aoki,Atsnshi,Fukuda,et al.Antibiotic substances:US,3950360[P].1976-04-13.
  • 8Fisher,Michael H,Tolman R L Carbohydrate derivatives of milbemycin and processes therefor:United States,4134973[P].1979-01-16.
  • 9Amano H,Ishi Y,Kobori Y.Pesticide susceptibility of two dominant Phytoseiid mites,Neoseiulus califomicus and N.womersleyi,in conventional Japanese fruit orchards (Gamosina:phytoseiidae)[J].JAcarol Soc Jpn,2004,13(1):65-70.
  • 10Plusehkell U,Horoeitz A R,Ishaaya I.Effect of Milbemectin on the swsetpotato whitefly,Bemisia tabaci[J].Phytoparnsities,1999,27(3):183-191.

二级参考文献73

  • 1冷阳,仲苏林,吴建兰,曹新梅,曹雄飞.农药水基化制剂的开发近况和有关深层次问题的讨论[J].农药科学与管理,2005,26(4):29-33. 被引量:36
  • 2吴蓉.我国农药产品的发展趋势[J].四川化工与腐蚀控制,2000,(5):6-6.
  • 3[1]Davies H G, Green R H. Avermectins and Milbemycins Part I [J]. Chem Soc Rev, 1991, 20: 211.
  • 4[2]a. Smith A B, Schow S R, Bloom J D, et al. Total synthesis of Milbemycin β3 [J]. J Am Chem Soc, 1982, 104: 4015-4018.b. Schow S R, Bloom J D, Thompson A S, et al. Milbemycin-Avermectin studies 5: Total synthesis of Milbemycin β3 and its C-2 epimer [J]. J Am Chem Soc, 1986,108, 2662.
  • 5[3]Baker G H,Blanchflower S E, Roderick J J, et al. Further novel Milbemycin antibiotics from Streptomycessp. E225 fermentation, isolation and structure elucidation [J]. J Antibiot, 1996,49: 272-280.
  • 6[4]Prichanrd R K,Pouliot J F, Georges E. Methods for using marcrocyclic lactone compounds as multiding resistance reversing agents in tumor and other cells [P]. WO 9848813, 1998-11-5.
  • 7[5]Takanashi S, Miyaoku H, Tanaka K, et al. Milbemycins α11,α12,α13,α14,α15 a new family of Milbemycins from Streptomyces hygroscopicus Subsp. Aureolacrimosus taxonymy, fermentation, isolation, structure elucidation and biological properties [J]. J Antibiot, 1993, 46( 9):1364-1371.
  • 8[6]Maeda H, Nishiyama S, Kojiima H, et al. Antiparisitic agent UK-86,956 manufacture with streptomyces [P]. EP 410615, 1991-1-30.
  • 9[7]Ouyang L. Melingmycin manufacture with strepotomyces [P]. CN 1070228, 1993-3-24.
  • 10[8]Haxell M A, Bishop B F, Bryce P, et al. C-13 β-acyloxy Milbemycins a new family of macrolides dicovery, structural determination and biological properties [J]. J Antibiot, 1992, 45(5): 659-670.

共引文献159

同被引文献58

  • 1刘翠翠,刘重喜,王相晶,向文胜.微生物农药米尔贝霉素特性[J].世界农药,2012,34(1):35-38. 被引量:5
  • 2夏广欣,刘重喜,王相晶,向文胜.微生物源农药米尔贝霉素的应用[J].世界农药,2012,34(3):35-39. 被引量:5
  • 3刘琳琳,刘翠翠,王相晶,夏广欣,向文胜.阿维菌素类和米尔贝霉素类杀虫剂的特性[J].世界农药,2012,34(5):34-39. 被引量:5
  • 4Angela D C, Gabriele B, Emanuela D G, et al. 2014. Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziqu- antel (Milbemax, Novartis Animal Health) in the che- moprevention of the zoonotic canine infection by Dirofi- laria repens[J]. Parasites and Vectors, 7: 347-354.
  • 5Baltz R H, Crawford K P, roughton M C, et al. 2001. Biosyn- thetic genes for spinosyn insecticide production. US Pat- ent 6274350[P].
  • 6Chen L, Chen J, Jiang Y Q, et al. 2009. Transcriptomics analy- ses reveal global roles of the regulator Avel in Strepto- myces avermitilis[J]. FEMS Microbiology Letters, 298 (2): 199-207.
  • 7Chio E H. 2011a. Spinosyn insecticides: Part Ⅰ. Blockbuster products from a remarkable discovery[J]. Formosan En- tomol, 31(1): 1-13.
  • 8Chio E H. 2011b. Spinosyn insecticides: Part Ⅱ. Triple win- ner of the US-EPA presidential green chemistry chal- lenge award[J]. Formosan Entomol, 31 (1): 15-23.
  • 9Claudia B, Manuela S, Stig M T, et al. 2014. Assessment of the combination of spinosad and milbemycin oxime in preventing the development of canine Angiostrongylus vasorum infections[J]. Veterinary Parasitology, 199(4) 272-277.
  • 10Crouse G D, Sparks T C, Schoonover J, et al. 2001. Recent ad- vances in the chemistry of spinosyns[J]. Pest Manage- ment Science, 57(2): 177-185.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部